Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Prostate Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03449719
What this trial is testing

Phase II Randomized Trial of Radiation Therapy in Oligometastatic mCRPC Prostate Cancer (ARTO)

Who this might be right for
Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone
Lorenzo Livi 174
Testing effectiveness (Phase 2)Active Not RecruitingNCT04748042
What this trial is testing

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

Who this might be right for
Prostate CancerCastrate Sensitive Prostate CancerOligometastatic Disease
University of Michigan Rogel Cancer Center 21
Large-scale testing (Phase 3)Looking for participantsNCT06972511
What this trial is testing

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
RenJi Hospital 120
Not applicableStudy completedNCT01859221
What this trial is testing

Radiotherapy for Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
University of Florida 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04619069
What this trial is testing

Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Very early researchStudy completedNCT03358563
What this trial is testing

Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07490210
What this trial is testing

Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
Fudan University 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05496959
What this trial is testing

177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study

Who this might be right for
Oligometastatic Prostate CarcinomaProstate AdenocarcinomaRecurrent Prostate Adenocarcinoma+1 more
Jonsson Comprehensive Cancer Center 93
Not applicableLooking for participantsNCT06389786
What this trial is testing

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

Who this might be right for
Localized Prostate CarcinomaOligometastatic Prostate CarcinomaStage I Prostate Cancer AJCC v8+3 more
Mayo Clinic 50
Testing effectiveness (Phase 2)UnknownNCT04031378
What this trial is testing

Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Adenocarcinoma
Fundacao Champalimaud 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03795207
What this trial is testing

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Who this might be right for
Node; ProstateBone MetastasesProstate Cancer Patients
Institut Cancerologie de l'Ouest 96
Testing effectiveness (Phase 2)Study completedNCT03298087
What this trial is testing

Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

Who this might be right for
Newly Diagnosed Oligometastatic Prostate Cancer
VA Office of Research and Development 28
Testing effectiveness (Phase 2)Study completedNCT02680587
What this trial is testing

Stereotactic Body Radiation for Prostate Oligometastases

Who this might be right for
Prostate CancerOligometastases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 80
Not applicableUnknownNCT04599686
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer

Who this might be right for
Treatment
Changhai Hospital 100
Not applicableActive Not RecruitingNCT03784755
What this trial is testing

Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Canadian Cancer Trials Group 409
Not applicableLooking for participantsNCT02971358
What this trial is testing

Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer

Who this might be right for
Locally Advanced and Metastatic Prostate Cancer
Medical University of Vienna 200
Not applicableLooking for participantsNCT06546267
What this trial is testing

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 2,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07807293
What this trial is testing

Radioguided Salvage Pelvic Node Dissection in Oligometastatic Prostate Cancer - SALVAGE

Who this might be right for
Prostate CancerOligometastatic
University of British Columbia 62
Not applicableLooking for participantsNCT07015138
What this trial is testing

Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer

Who this might be right for
Prostate CancerOligometastatic Prostate Cancer
Peking University First Hospital 390
Testing effectiveness (Phase 2)Looking for participantsNCT06387056
What this trial is testing

Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)

Who this might be right for
Locally Advanced Prostate CancerOligometastatic Prostate Cancer
The First Affiliated Hospital of Xiamen University 40
Next Page